These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15488761)

  • 1. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
    Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
    Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
    Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
    Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
    Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
    Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.
    Chen WY; Zeng X; Carter MG; Morrell CN; Chiu Yen RW; Esteller M; Watkins DN; Herman JG; Mankowski JL; Baylin SB
    Nat Genet; 2003 Feb; 33(2):197-202. PubMed ID: 12539045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
    Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas.
    Augello C; Gregorio V; Bazan V; Cammareri P; Agnese V; Cascio S; Corsale S; Calò V; Gullo A; Passantino R; Gargano G; Bruno L; Rinaldi G; Morello V; Gerbino A; Tomasino RM; Macaluso M; Surmacz E; Russo A
    J Cell Physiol; 2006 Jun; 207(3):654-9. PubMed ID: 16447252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
    Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.
    Parrella P; Scintu M; Prencipe M; Poeta ML; Gallo AP; Rabitti C; Rinaldi M; Tommasi S; Paradiso A; Schittulli F; Valori VM; Toma S; Altomare V; Fazio VM
    Cancer Lett; 2005 May; 222(1):75-81. PubMed ID: 15837543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.
    Dehennaut V; Leprince D
    Bull Cancer; 2009 Nov; 96(11):E66-72. PubMed ID: 19822477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conditional mouse model for malignant mesothelioma.
    Jongsma J; van Montfort E; Vooijs M; Zevenhoven J; Krimpenfort P; van der Valk M; van de Vijver M; Berns A
    Cancer Cell; 2008 Mar; 13(3):261-71. PubMed ID: 18328429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of tumor suppressor genes: choice between genetic and epigenetic routes.
    Chen WY; Baylin SB
    Cell Cycle; 2005 Jan; 4(1):10-2. PubMed ID: 15611624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.